Sexual dimorphism in the response of thoracic aorta from SHRs to losartan

General Pharmacology: The Vascular System

Volumn 34, Issue 5, 2000, Pages 329-335

  Silva Antonialli, M M ^a   Fortes, Z B ^a   Carvalho, M H C ^a   Scivoletto, R ^a   Nigro, D ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aorta; Endothelial dysfunction; Losartan; SHR

Indexed keywords

ACETYLCHOLINE; DAZOXIBEN; LOSARTAN; NITROPRUSSIDE SODIUM; NORADRENALIN; RIDOGREL; THROMBOXANE RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTERIAL PRESSURE; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; ESTRUS; FEMALE; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT; THORACIC AORTA; TREATMENT OUTCOME; VASCULAR RING;

ACETYLCHOLINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, THORACIC; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HYPERTENSION; LOSARTAN; MALE; RATS; RATS, INBRED SHR; RATS, WISTAR; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; VASODILATOR AGENTS;

EID: 0034444872     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(00)00078-1     Document Type: Article

References (29)

1. Arvola, P., Ruskoaho, H., Pekki, A., Vapastalo, H., Porsti, I., 1993. Quinapril treatment and arterial smooth muscle response in spontaneously hypertensive rats. Br. J. Pharmacol. 108, 980-990.
2. Bertolino, F., Valentin, J.P., Maflre, M., Jover, B., Bessac, A.M., John, G., 1993. Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist. J. Pharmacol. Exp. Then 268, 747-752.
3. Bouloumie, A., Bauersachs, J., Linz, W., Schölkens, B.A., Wiemer, G., Fleming, I., Busse, R., 1997. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension 30, 934-941.
4. Cachofeiro, V., Maeso, R., Rodrigo, E., Navarro, J., Ruilope, L.M., Lahera, V., 1995. Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension. Hypertension 26, 236-243.
5. Carvalho, M.H.C., Scivoletto, R., Fortes, Z.B., Nigro, D., Cordelline, S., 1987. Reactivity of aorta and mesenteric microvessels to drugs in spontaneously hypertensive rats: role of the endothelium. J. Hypertens. 5, 377-382.
6. Clozel, M., Kuhn, H., Hefti, E, 1990. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 16, 532-540.
7. Dohi, Y., Criscione, L., Pfeiffer, K., Luscher, T.F., 1994. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries. J. Cardiovasc. Pharmacol. 24, 372-379.
8. Furchgott, R.F., Zawadzki, J.V., 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376.
9. Ge, T., Hughes, H., Junquero, D.C., Wu, K.K., Vanhoutte, P.M., Boulanger, C.M., 1995. Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ. Res. 76, 1003-1010.
10. Goehlke, P., Linz, W., Schölkens, B.A., Wiemer, G., Unger, T., 1996. Cardiac and vascular effects of long-term losartan treatment in strokeprone spontaneously hypertensive rats. Hypertension 28, 397-402.
11. Grunfeld, S., Hamilton, C.A., Mesaros, S., McClain, S.W., Dominiczak
12. D.F., Bohr, D.F., Malinski, T., 1995. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 26, 854-857.
13. Jaiswal, N., Diz, D.I., Tallant, E.A., Khosla, M.C., Ferrario, C.M., 1991. The nonpeptide angiotensin II antagonist DuP 753 is a potent stimulus for prostacyclin synthesis. Am. J. Hypertcns. 4 (Suppl. 3), 228-233.
14. 2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension 15, 475-482.
15. Lefkowitz, R.J., Hoffman, B.B., Taylor, P., 1996. Neurotransmission-the autonomie and somatic motor nervous systems. Goodman and Gilman's the Pharmacological Basis of Therapeutics. International Edition, 9th ed. McGraw-Hill, pp. 105-139.
16. Li, P., Ferrario, C.M., Brosnihan, K.B., 1997. Nonpeptide angiotensin II antagonist losartan inhibits thromboxane A2 induced contractions in canine coronary arteries. J. Pharmacol. Exp. Ther. 281, 1065-1070.
17. Linder, L., Kiowski, W., Buhler, F.R., Luscher, T.F., 1990. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 81, 1762-1767.
18. Lockette, W.E., Otsuha, Y., Carretero, A.O., 1986. The loss of endotheliumdependent vascular relaxation in hypertension. Hypertension 8 (Suppl. II), 61-66.
19. Lüscher, T.F., Vanhoutte, P.M., 1986. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 8, 344-348.
20. Moriguchi, A., Brosnihan, K.B., Kumagai, H., Ganten, D., Ferrario, C.M., 1994. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am. J. Physiol. 266, R1273-R1278.
21. 1 receptor gene expression in vitro and in vivo. Circulation 97, 2197-2201.
22. Nigro, D., Fortes, Z.B., Carvalho, M.H.C., Scivoletto, R., 1989. Chronic but not acute treatment with hydralazine reverses the decreased endothelium-dependent responses in spontaneously hypertensive rats. Clin. Exp. Hypertension 11, 573-586.
23. Nigro, D., Fortes, Z.B., Scivoletto, R., Barbeiro, U.V., Carvalho, M.H.C., 1997. Sex-related differences in the response of spontaneously hypertensive rats to angiotensin-converting enzyme inhibitor. Endothelium, 63-71.
24. Rapoport, R.M., Murad, F., 1983. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ. Res. 52, 352-357.
25. Taddei, S., Virdis, A., Mattei, P., Salvetti, A., 1993. Vasodilatation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21, 929-933.
26. Timmermans, P.B.M.W.M., Wong, P.C., Chiu, A.T., Herblin, W.F., Benfield, P., Carini, D.J., Lee, R.J., Wexler, R.R., Saye, J.A.M., Smith, R.D., 1993. Angiotensin II receptors and angiotensin II receptors antagonists. Pharmacol. Rev. 45, 205-251.
27. Townsend, R.R., Ford, V., 1996. Clinical Pharmacology and use of the selective ATI receptor antagonist losartan in hypertension. J. New Dev. Clin. Med. 13, 195-206.
28. Tschudi, M.R., Criscione, L., Novorsel, D., Pfeiffer, K., Lüscher, T.F., 1994. Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats. Circulation 89, 2212-2218.
29. Watt, P.A.C., Thurton, H., 1989. Endothelium-dependent relaxation in resistance vessels from spontaneously hypertensive rats. J. Hypertens. 7, 661-666.